Amgen Dividenden en inkoop
Dividend criteriumcontroles 4/6
Amgen is een dividendbetalend bedrijf met een huidig rendement van 2.8%. Volgende betalingsdatum is op 9th December, 2024 met een ex-dividenddatum van 18th November, 2024.
Belangrijke informatie
2.8%
Dividendrendement
0%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 2.8% |
| Toekomstig dividendrendement | 3.2% |
| Dividendgroei | 3.9% |
| Volgende betaaldatum dividend | 09 Dec 24 |
| Ex-dividenddatum | 18 Nov 24 |
| Dividend per aandeel | US$9.000 |
| Uitbetalingsratio | 113% |
Recente updates van dividend en inkoop
Recent updates
Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market
Nov 03Amgen Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 02
Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List
Oct 25Amgen: Pipeline Updates, Uplizna Performs And Rocatinlimab Underwhelms
Sep 26Amgen: Growth Is Still A Better Choice
Aug 28Amgen Inc. Just Missed EPS By 46%: Here's What Analysts Think Will Happen Next
Aug 09Amgen: Shows Why Dividend Investing Is Getting Tougher
Aug 07Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26The Price Is Right For Amgen Inc. (NASDAQ:AMGN)
Jul 11Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 05Amgen: You Haven't Seen Anything Yet
Jun 17Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
Jun 04Amgen Stock: Poised To Break Out (Technical Analysis)
May 21Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?
May 04Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
May 01Amgen: The Giant With An Impressive Pipeline
Apr 15Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
Mar 31Amgen Will Benefit From Increased Medical Spending
Mar 12Amgen: A Good Dividend Growth Stock For The Watch List
Mar 04Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit
Feb 21Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now
Feb 16Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
Feb 08Amgen: Accelerating The Business And Dividend Growth
Jan 29Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?
Jan 29Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
Jan 22Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors
Dec 13Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?
Oct 23Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?
Sep 04Komende dividendbetaling
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Het dividend per aandeel van AMGN is de afgelopen 10 jaar stabiel gebleven.
Groeiend dividend: De dividendbetalingen van AMGN zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
| Amgen Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (AMGN) | 2.8% |
| Markt onderkant 25% (US) | 1.4% |
| Markt Top 25% (US) | 4.4% |
| Gemiddelde industrie (Biotechs) | 2.1% |
| Analist prognose (AMGN) (tot 3 jaar) | 3.2% |
Opmerkelijk dividend: Het dividend van AMGN ( 2.8% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de US markt ( 1.37% ).
Hoog dividend: Het dividend AMGN ( 2.8% ) is laag vergeleken met de top 25% van dividendbetalers in de US markt ( 4.36% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Gezien de hoge payout ratio ( 112.6% ) worden de dividendbetalingen van AMGN niet goed gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Op basis van de huidige cash payout ratio ( 77% ) worden de dividendbetalingen van AMGN gedekt door kasstromen.